Speaker Profile

Ph.D., Vice President, Head of Clinical Science, Everlywell

Biography
Dr. Tim Bauer is the Vice President, Head of Clinical Science at Everlywell, the digital health company poised to disrupt the 25 billion dollar lab testing industry by providing consumers with at-home lab testing kits that include insightful, easy-to-understand results. Prior to joining Everlywell, Dr. Bauer held leadership and senior clinical scientist positions at biotechnology companies such as SomaLogic and Gilead Sciences. An expert in clinical research with over two decades of experience, he also spent several years developing clinical trials for CPC Clinical Research. Dr Bauer continues to serve as an adjunct faculty and researcher at the University of Colorado School of Medicine, where he has received research grants from the American Heart Association and the National Institutes of Health (NIH). Dr. Bauer earned a Ph.D. in Physiology from Kansas State University and a B.S. and M.S. in Exercise Physiology from Colorado State University. He continued his clinical research training at the University of Colorado School of Medicine, where he completed post-doctoral fellowships in Cardiology and Endocrinology. He resides in Austin, Texas.


Health Monitoring Showcase:
Everlywell

Everlywell is a digital health company that provides consumers with access to a suite over validated at-home lab testing kits that include insightful, easy-to-understand results. The company was founded in 2015 and is based in Austin, Texas.

Consumer Testing And Precision Medicine: Past, Present, And Future
Combining genotypic and phenotypic data to provide tailored healthcare is the vision of precision medicine, yet the testing industry was quicker to bring consumer genomics to market than consumer testing for basic biomarkers such as hormones, vitamins, and markers associated with chronic conditions. This session will discuss the past, present and future of precision medicine using this lens.

 Session Abstract – PMWC 2020 Silicon Valley


The PMWC 2020 Health Monitoring Showcase will provide 15 minute speaking opportunities for selected companies working with the latest technologies in remote patient and care monitoring, providing devices that are smart and integrated with high-touch approaches, sensors, data collection and analytical capabilities translating patient vital signs into useful insights and alert triggers. These companies will share their innovative products to an audience of leading investors, potential clients, and partners. The PMWC 2019 Health Monitoring Showcase will exhibit the latest innovations that lead to products, systems, and services that empower patients with chronic conditions to better understand and self-manage their conditions and provide clinicians with easy, efficient monitoring that enhance patients’ lives and enable the delivery of better outcomes at lower cost.